Literature DB >> 33659348

Generation and Testing of Fluorescent Adaptable Simple Theranostic (FAST) Proteins.

Andrew S Flies1, Jocelyn M Darby1, Peter R Murphy1,2, Terry L Pinfold3, Amanda L Patchett1, Patrick R Lennard1,4.   

Abstract

This protocol provides a step-by-step method to create recombinant fluorescent fusion proteins that can be secreted from mammalian cell lines. This builds on many other recombinant protein and fluorescent protein techniques, but is among the first to harness fluorescent fusion proteins secreted directly into cell culture supernatant. This opens new possibilities that are not achievable with proteins produced in bacteria or yeast, such as direct use of the fluorescent protein-secreting cells in live co-culture assays. The Fluorescent Adaptable Simple Theranostic (FAST) protein system includes a histidine purification tag and a tobacco etch virus (TEV) cleavage site, allowing the purification tag and fluorescent protein to be removed for therapeutic use. This protocol is split into five parts: (A) In silico characterization of the gene-of-interest (GOI) and protein-of-interest (POI); (B) design of the expression vector; (C) assembly of the expression vector; (D) transfection of a eukaryotic cell line with the expression vector; (E) testing of the recombinant protein. This extensive protocol can be completed with only polymerase chain reaction (PCR) and cell culture training. Additionally, each part of the protocol can be used independently.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Comparative immunology; Fluorescent; Fusion protein; Non-model organism; Recombinant; Soluble; Trans-endocytosis

Year:  2020        PMID: 33659348      PMCID: PMC7842535          DOI: 10.21769/BioProtoc.3696

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Enzymatic assembly of DNA molecules up to several hundred kilobases.

Authors:  Daniel G Gibson; Lei Young; Ray-Yuan Chuang; J Craig Venter; Clyde A Hutchison; Hamilton O Smith
Journal:  Nat Methods       Date:  2009-04-12       Impact factor: 28.547

2.  Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines.

Authors:  Eric Kowarz; Denise Löscher; Rolf Marschalek
Journal:  Biotechnol J       Date:  2015-03-02       Impact factor: 4.677

3.  Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.

Authors:  Omar S Qureshi; Yong Zheng; Kyoko Nakamura; Kesley Attridge; Claire Manzotti; Emily M Schmidt; Jennifer Baker; Louisa E Jeffery; Satdip Kaur; Zoe Briggs; Tie Z Hou; Clare E Futter; Graham Anderson; Lucy S K Walker; David M Sansom
Journal:  Science       Date:  2011-04-07       Impact factor: 47.728

4.  UniProt: a worldwide hub of protein knowledge.

Authors: 
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

5.  GenBank.

Authors:  Dennis A Benson; Mark Cavanaugh; Karen Clark; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; Eric W Sayers
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

6.  Ensembl 2018.

Authors:  Daniel R Zerbino; Premanand Achuthan; Wasiu Akanni; M Ridwan Amode; Daniel Barrell; Jyothish Bhai; Konstantinos Billis; Carla Cummins; Astrid Gall; Carlos García Girón; Laurent Gil; Leo Gordon; Leanne Haggerty; Erin Haskell; Thibaut Hourlier; Osagie G Izuogu; Sophie H Janacek; Thomas Juettemann; Jimmy Kiang To; Matthew R Laird; Ilias Lavidas; Zhicheng Liu; Jane E Loveland; Thomas Maurel; William McLaren; Benjamin Moore; Jonathan Mudge; Daniel N Murphy; Victoria Newman; Michael Nuhn; Denye Ogeh; Chuang Kee Ong; Anne Parker; Mateus Patricio; Harpreet Singh Riat; Helen Schuilenburg; Dan Sheppard; Helen Sparrow; Kieron Taylor; Anja Thormann; Alessandro Vullo; Brandon Walts; Amonida Zadissa; Adam Frankish; Sarah E Hunt; Myrto Kostadima; Nicholas Langridge; Fergal J Martin; Matthieu Muffato; Emily Perry; Magali Ruffier; Dan M Staines; Stephen J Trevanion; Bronwen L Aken; Fiona Cunningham; Andrew Yates; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers.

Authors:  Andrew S Flies; Jocelyn M Darby; Patrick R Lennard; Peter R Murphy; Chrissie E B Ong; Terry L Pinfold; Alana De Luca; A Bruce Lyons; Gregory M Woods; Amanda L Patchett
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

  7 in total
  2 in total

1.  Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.

Authors:  Chrissie E B Ong; Yuanyuan Cheng; Hannah V Siddle; A Bruce Lyons; Gregory M Woods; Andrew S Flies
Journal:  Open Biol       Date:  2022-10-19       Impact factor: 7.124

2.  NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.

Authors:  Chrissie E B Ong; Amanda L Patchett; Jocelyn M Darby; Jinying Chen; Guei-Sheung Liu; A Bruce Lyons; Gregory M Woods; Andrew S Flies
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.